chr12-80254580-T-A
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1
The NM_001378609.3(OTOGL):c.1441+10T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000849 in 1,599,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001378609.3 intron
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 84BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -16 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001378609.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOGL | NM_001378609.3 | MANE Select | c.1441+10T>A | intron | N/A | NP_001365538.2 | |||
| OTOGL | NM_001378610.3 | c.1441+10T>A | intron | N/A | NP_001365539.2 | ||||
| OTOGL | NM_173591.7 | c.1441+10T>A | intron | N/A | NP_775862.4 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OTOGL | ENST00000547103.7 | TSL:5 MANE Select | c.1441+10T>A | intron | N/A | ENSP00000447211.2 | |||
| OTOGL | ENST00000646859.1 | c.1441+10T>A | intron | N/A | ENSP00000496036.1 | ||||
| OTOGL | ENST00000643417.1 | n.2101+10T>A | intron | N/A |
Frequencies
GnomAD3 genomes AF: 0.000619 AC: 94AN: 151934Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000981 AC: 240AN: 244652 AF XY: 0.000917 show subpopulations
GnomAD4 exome AF: 0.000874 AC: 1264AN: 1446948Hom.: 0 Cov.: 29 AF XY: 0.000851 AC XY: 613AN XY: 720140 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000618 AC: 94AN: 152052Hom.: 0 Cov.: 32 AF XY: 0.000673 AC XY: 50AN XY: 74338 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not specified Benign:1
c.1414+10T>A in intron 14 of OTOGL: This variant is not expected to have clinica l significance because it is not located within the splice consensus sequence. I t has been identified in 0.4% (131/34138) of Latino chromosomes by the Genome Ag gregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs367996419) .
OTOGL-related disorder Benign:1
This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at